IP Library Granted Patent US 6,855,161
Granted Patent B2
US 6,855,161 · App. 09/752,212 · Granted Feb 15, 2005

Radiopaque nitinol alloys for medical devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,855,161
App. No.
09/752,212
Granted
Feb 15, 2005
Kind
B2
Abstract

A radiopaque nitinol medical device such as a stent for use with or implantation in a body lumen is disclosed. The stent is made from a superelastic alloy such as nickel-titanium or nitinol, and includes a ternary element selected from the group of chemical elements consisting of iridium, platinum, gold, rhenium, tungsten, palladium, rhodium, tantalum, silver, ruthenium, or hafnium. The added ternary element improves the radiopacity of the nitinol stent comparable to that of a stainless steel stent of the same size and strut pattern coated with a thin layer of gold. The nitinol stent has improved radiopacity yet retains its superelastic and shape memory behavior and further maintains a thin strut/wall thickness for high flexibility.

Claims (11)

1. A method for providing a superelastic, radiopaque metallic stent for medical applications, comprising:

providing a tubular-shaped body having a thin wall, wherein the body includes a superelastic nickel-titanium alloy and the alloy further includes a ternary element selected from the group of chemical elements consisting of: iridium, platinum, gold, rhenium, tungsten, palladium, rhodium, tantalum, silver, ruthenium, or hafnium;

wherein the step of providing a tubular-shaped body includes melting nickel, titanium, and the ternary element, cooling to form an alloy ingot, hot forming the alloy ingot, forming the alloy ingot into a cylinder, drilling the cylinder to form tubing, drawing the tubing, and annealing the tubing, forming a strut pattern;

wherein the stent is radiopaque.

2. The method of claim 1 , wherein the atomic percent of platinum is greater than 2.5 and less than or equal to 15.

3. The method of claim 1 , wherein the atomic percent of palladium is greater than 2.5 and less than or equal to 20.

4. The method of claim 1 , wherein an austenite finish temperature (A f ) of the superelastic alloy in the stent is greater than or equal to about zero and less than or equal to about 37 degrees C.

5. The method of claim 1 , wherein the ingot after melting includes an austenite finish temperature (A f ) of greater than or equal to about 0 degrees C. and less than or equal to about 40 degrees C.

6. The method of claim 1 , wherein the tubing includes an austenite finish temperature (A f ) of greater than or equal to about −15 degrees C. and less than or equal to about 15 degrees C.

7. The method of claim 1 , wherein the ingot is remelted.

8. The method of claim 1 , wherein the alloy includes a quaternary element.

Assignments (2)
CHANGE OF NAME Recorded Apr 25, 2007
From: ADVANCED CARDIOVASCULAR SYSTEMS, INC.
To: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Reel/Frame 019235/0557 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2000
From: BOYLAN, JOHN F.; COX, DANIEL L.
To: ADVANCED CARDIOVASCULAR SYSTEMS, INC.
Reel/Frame 011417/0537 →